INJECTION NEEDLE
Report
- Report Number
- 3005099803-2011-00782
- Event Type
- Malfunction
- Date Received
- March 10, 2011
- Date of Event
- February 18, 2011
- Report Date
- February 18, 2011
- Manufacturer
- BOSTON SCIENTIFIC - MARLBOROUGH
- Product Code
- KOG
- PMA / PMN Number
- K953338
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- PHYSICIAN
Narratives
THE DEVICE HAS BEEN RECEIVED BY THIS MANUFACTURER, HOWEVER, THE INVESTIGATION HAS NOT YET BEEN PERFORMED. UPON COMPLETION OF THE FAILURE ANALYSIS OF THE COMPLAINT DEVICE, IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED.
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN OPTIFLO INJECTION NEEDLE WAS INTENDED FOR USE DURING A COLONOSCOPY PROCEDURE. ACCORDING TO THE COMPLAINANT, DURING PREPARATION, THE NURSE FOUND THAT THERE WAS A RAZOR IN THE STERILE PACKAGING OF THE DEVICE. NO ONE WAS HARMED BY THE RAZOR. THE PACKAGE WAS SET ASIDE, AND A NEW OPTIFLO DEVICE WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. AT THE CONCLUSION OF THE PROCEDURE, THE PATIENT'S CONDITION WAS REPORTED TO BE FINE.
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN OPTIFLO INJECTION NEEDLE WAS INTENDED FOR USE DURING A COLONOSCOPY PROCEDURE.ACCORDING TO THE COMPLAINANT, DURING PREPARATION, THE NURSE FOUND THAT THERE WAS A RAZOR IN THE STERILE PACKAGING OF THE DEVICE. NO ONE WAS HARMED BY THE RAZOR. THE PACKAGE WAS SET ASIDE, AND A NEW OPTIFLO DEVICE WAS USED TO COMPLETE THE PROCEDURE.NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. AT THE CONCLUSION OF THE PROCEDURE, THE PATIENT'S CONDITION WAS REPORTED TO BE FINE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | INJECTION NEEDLE | ENDOSCOPE AND/OR ACCESSORIES | KOG | BOSTON SCIENTIFIC - MARLBOROUGH | M00511751 | 0000757843 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 39 YR |